North America Analysis
Home Search

gene therapy - search results

If you're not happy with the results, please do another search
protect hair from chemotherapy, cancer medicine

Scientists discover way to protect hair from chemotherapy

Scientists have determined a new way to protect the hair follicle from chemotherapy in an effort to prevent hair loss as a result of cancer treatments.
metabolic, diabetes therapy

Metabolic data key to individualise diabetes therapy

Peter Robins, from Metabolic Health Solutions (MHS), describes how a new clinical management tool can help individualise treatment of obesity and Type 2 diabetes.
neurodegenerative diseases

New treatments for neurodegenerative diseases

Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
new genes

RCSI research finds eleven new genes associated with epilepsy

Researchers at the Royal College of Surgeons (RCSI) in Ireland have found new genes linked to epilepsy which could inform the development of new treatments for the condition
Dystrophin gene

Duchenne muscular dystrophy (DMD): Correcting the dystrophin gene

Dr Ahlke Heydemann, Associate Professor and Director of Medical School Curriculum at University of Illinois, Chicago explains Duchenne muscular dystrophy (DMD), focussing on the issue of correcting the dystrophin gene
radiotherapy

Experts say radiotherapy is ‘undervalued’ and ‘needs greater investment’

A new report by the Marie Curie Legacy campaign suggests at least a quarter of cancer patients in Europe who need radiotherapy don't receive it.
Neurodegenerative disorders

Neurodegenerative disorders in the U.S.

The vital work of the National Institute on Deafness and Other Communication Disorders (NIDCD) and The National Institute of Neurological Disorders and Stroke (NINDS) are explored here by Open Access Government, with a special focus on neurodegenerative disorders.
Alzheimer’s disease

Infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease

Tamas Fulop from Université de Sherbrooke’s Research Center on Aging, explains precisely why infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease (AD)
acute myeloid leukaemia

CD33-directed therapy: Current and future perspectives on targeted therapy in acute myeloid leukaemia (AML)

Mohammed Gbadamosi and Jatinder K Lamba from Department of Pharmacotherapy and Translational Research at the University of Florida explain CD33-directed therapy for acute myeloid leukaemia (AML), focussing on current and future perspectives
tissue regeneration

Rediscovering observations of the environmental factors affecting tissue regeneration in aquatic species

Graciela A. Unguez, PhD, Professor of Biology and student Bahiyyih Mitchell at New Mexico State University explore the environmental factors affecting tissue regeneration in aquatic species

Cancer immunotherapy therapy is here and now

Stephanie K. Watkins PhD from Loyola University Chicago shares her views on cancer immunotherapy therapy – the concept of using the immune system to fight and destroy cancer cells
skin cancer progression

Sunlight-induced carcinogenesis: Angiogenesis in skin cancer progression

Dr Olga V Volpert’s work on sunlight-induced carcinogenesis at the MD Anderson Cancer Center is explored here, including why angiogenesis is critically important in skin cancer progression
Cancer therapy

The current and future challenges of personalised cancer therapy

Managing Director of The Cancer Drug Development Forum, Prof. H. Zwierzina reveals his opinions on the current and future challenges of personalised cancer therapy, including the need for biomarkers.
Department of Pharmacotherapy and Translational Research

Department of Pharmacotherapy and Translational Research

The Department of Pharmacotherapy and Translational Research provides classroom and clinical instruction for pharmacy students and trains graduate students in clinical translational research. The Department of Pharmacotherapy and Translational Research is proud of its national reputation as a leader in the areas of pharmacy practice, education and clinical translational research....

PET imaging of neurodegenerative diseases

Prof. Dr Axel Rominger from the Ludwig-Maximilian-University of Munich on how neurodegenerative diseases can be studied through PET imaging
chemotherapy data

Publishing national chemotherapy data

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

Personalising antibody directed therapy in Acute Myeloid Leukaemia (AML)

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research explores the current progress in Acute Myeloid Leukaemia (AML)
nerve stimulator

Man in vegetative state regains some consciousness through nerve stimulator therapy

A man in a vegetative state in France has regained a degree of consciousness after experimental therapy of placing a nerve stimulator on his chest After being in a vegetative state for 15 years, the unnamed 35-year-old patient responded to nerve stimulator therapy and within a month was able to...

Can a new light-based therapy help with Alzheimer’s disease?

Prof Michael R Hamblin of the Wellman Center for Photomedicine at Massachusetts General Hospital discusses a new light-based therapy for Alzheimer’s disease

Photodynamic Therapy – radiotherapy for the 21st Century

Photodynamic Therapy is a treatment that combines a photosensitizing drug, visible light and oxygen to kill cancer cells. Professor Eli Glatstein explains

Follow Open Access Government